What is the 13F Pro Quality Score for UNH?

13F Pro ranks UNITEDHEALTH GROUP INC (UNH) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View UNH's current score at https://13fpro.ai/company/UNH (free sign-up required for the full ranking).

Which hedge funds own the most UNH stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of UNH include BlackRock,, VANGUARD CAPITAL MANAGEMENT, STATE STREET. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/company/UNH as soon as new 13F filings post.

Where does 13F Pro source UNH data?

All UNITEDHEALTH GROUP INC fundamentals and ownership data come directly from SEC EDGAR. UNITEDHEALTH GROUP INC files with the SEC under CIK 731766. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is UNH in?

UNITEDHEALTH GROUP INC (UNH) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

What drives UNH's revenue?

Per UNITEDHEALTH GROUP INC's latest 10-Q filed with the SEC on 2026-08-10, the biggest revenue drivers are: UnitedHealthcare ($86.0B, 0% YoY); Optum Rx ($38.3B, 0% YoY); UnitedHealthcare Medicare & Retirement ($42.4B, -1% YoY). Figures are extracted from the filing text and machine-verified against the document. Full breakdown at https://13fpro.ai/company/UNH.

What are UNH's largest expenses?

UNITEDHEALTH GROUP INC's latest 10-Q reports these as the largest expense items: Medical costs ($75.4B, -4% YoY); Operating costs ($14.3B, +4% YoY); Cost of products sold ($13.4B, +3% YoY). Sourced directly from SEC EDGAR filing text for Q2 2026 (quarter ended June 30, 2026).

How often is UNH research updated on 13F Pro?

UNH's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

UNITEDHEALTH GROUP INC(UNH)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →NYSEmega

Institutional-grade research for retail investors

SEC EDGAR: CIK 731766 UNH stock profile & AI dashboard →

13F Pro Quality Score

62.7/100

Rank #687 of 2,961 stocksTOP 25%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

54.4/100

Profitability

37.9/100

Balance Sheet

67.7/100

Earnings Quality

82.5/100

Free Cash Flow

43.1/100

Institutional Flow

68.7/100

Revenue Scale

99.8/100

Dilution Risk

85.0/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why UNH Scores 63/100

exact factor attribution · 2026-09-11

UNH's composite is driven by scale and earnings quality, held back by profitability and free cash flow. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Scale

+7.5 pts

100th pct

Earnings quality

+3.3 pts

83th pct

Capital efficiency

+1.8 pts

68th pct

Shareholder dilution

+1.8 pts

85th pct

Institutional flow

+0.9 pts

69th pct

Revenue growth

+0.9 pts

54th pct

Earnings growth

-0.5 pts

40th pct

Free cash flow

-1.0 pts

43th pct

Profitability

-1.8 pts

38th pct

Latest change (2026-08-10): 67 → 60 · ↓ Revenue growth 62→48; ↓ Profit margin 53→42

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

UNH Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for UNITEDHEALTH GROUP INC (UNH), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores UNH at 62.7/100 on a 32-signal composite quality model, placing it at rank #687 of 2,961 stocks — the top 25% of the AI-ranked universe. UNH scores in the top quartile across revenue scale (99.8), earnings quality (82.5). Areas of concern include profitability (37.9), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), UNITEDHEALTH GROUP INC reports quarterly revenue of $112.0B, net income of $5.5B, an operating margin of 7.1%. Top institutional holders of UNH by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, STATE STREET, based on the most recent SEC filings. UNH trades on the NYSE exchange and files with the SEC under CIK 731766. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate UNH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for UNITEDHEALTH GROUP INC directly from SEC EDGAR. UNITEDHEALTH GROUP INC's 13F Pro composite quality score has ranged between 60 and 72 since 2021, currently 62.7 — a declining long-term trajectory across 68 quarterly and live scoring snapshots.

✦

Fun facts about UNITEDHEALTH GROUP INC

Quirks, history, and lore behind UNH — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. healthcare company · mega-cap · listed on the NYSE · headquartered in Minnesota.
2
The Numbers
Revenue of roughly $370 billion a year, making it one of the largest companies on earth by sales — yet most Americans couldn't pick its logo out of a lineup.
3
The History
Founded in 1977 by a physician and a hospital administrator, it grew by consolidating managed care plans and eventually became the dominant force in U.S. health insurance.
4
The Secret
It runs two massive businesses under one roof: a health insurance giant and a separate pharmacy-and-data arm that quietly powers prescription benefits for tens of millions of people.
5
The Lore
Its Optum division employs more physicians than any other organization in the U.S., and the company landed in the center of a national conversation after a high-profile executive killing in late 2024.
6
The Giveaway
The largest U.S. health insurer, based in Minnesota, whose three letters on the NYSE have become shorthand for everything Americans love — and love to hate — about health insurance.

▶ Think you know your stocks? Play the Daily Ticker

What's Driving UNH's Business? Latest 10-Q Breakdown

AI-extracted from UNITEDHEALTH GROUP INC's 10-Q filed 2026-08-10 — Q2 2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Revenue was essentially flat at $112.0B, but the medical care ratio fell 2.7 points to 86.7%, lifting earnings from operations 55% to $8.0B and diluted EPS to $6.04.

Biggest Revenue Drivers

UnitedHealthcare$86.0B0% YoY

Contraction in Medicare Advantage, risk-based commercial and Medicaid members, offset by pricing trends and fee-based growth

Optum Rx$38.3B0% YoY

Reduced script volume from contraction in people served at UnitedHealthcare, partially offset by retail and specialty pharmacy growth

Biggest Revenue Drivers

Total revenue: $112.0B0% YoY

UnitedHealthcare$86.0B0% YoY

Contraction in Medicare Advantage, risk-based commercial and Medicaid members, offset by pricing trends and fee-based growth

Within UnitedHealthcare

UnitedHealthcare Medicare & Retirement$42.4B-1% YoY

Optum Rx$38.3B0% YoY

Reduced script volume from contraction in people served at UnitedHealthcare, partially offset by retail and specialty pharmacy growth

Largest Expense Items

Medical costs$75.4B-4% YoY

Fewer people served and favorable prior period reserve development, partly offset by elevated medical cost trend

Operating costs$14.3B+4% YoY

Investments in people, process and technology, and business mix

Cost of products sold$13.4B+3% YoY

Depreciation and amortization$1.0B-4% YoY

Margins: Medical care ratio fell to 86.7% from 89.4% on favorable prior period development, affordability initiatives and pricing; operating cost ratio rose 0.4 points to 12.7%, with operating margin at 7.1%.

Watch Items from the Filing

IRS Notices of Proposed Adjustment received March 6, 2026 on 2017-2020 intercompany transfer pricing; company intends to contest and may face similar adjustments after 2020.
DOJ False Claims Act case on Medicare risk adjustment remains unresolved; a Special Master recommended summary judgment for the company, which DOJ moved to reject.
Company pledged to rebate 2026 profits on individual exchange products, and Medicare Advantage 2027 rate notice remains below forward medical cost trend.
South American businesses held for sale carry a $1,656M remeasurement to fair value less cost to sell, including $893M of cumulative foreign currency translation losses.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →Share on X

Revenue

Q2 2026

$112.0B

Net Income

Q2 2026

$5.5B

Free Cash Flow

Q2 2026

$10.3B

Operating Margin

Q2 2026

7.1%

ROIC

Q2 2026

18.0%

D/E Ratio

Q2 2026

0.70

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+11.8% YoY

$447.57BFY 2025

FY22 $324.16BFY23 $371.62BFY24 $400.28BFY25 $447.57B

Net Income

-16.3% YoY

$12.06BFY 2025

FY22 $20.12BFY23 $22.38BFY24 $14.40BFY25 $12.06B

Operating Income

-41.3% YoY

$18.96BFY 2025

FY22 $28.43BFY23 $32.36BFY24 $32.29BFY25 $18.96B

EPS (Diluted)

-14.7% YoY

$13.23FY 2025

FY22 $21.18FY23 $23.86FY24 $15.51FY25 $13.23

Total Assets

+3.8% YoY

$309.58BFY 2025

FY22 $245.71BFY23 $273.72BFY24 $298.28BFY25 $309.58B

Total Debt

+2.0% YoY

$77.68BFY 2025

FY22 $56.76BFY23 $61.47BFY24 $76.18BFY25 $77.68B

Op. Cash Flow

-18.6% YoY

$19.70BFY 2025

FY22 $26.21BFY23 $29.07BFY24 $24.20BFY25 $19.70B

Free Cash Flow

-22.4% YoY

$16.07BFY 2025

FY22 $23.40BFY23 $25.68BFY24 $20.70BFY25 $16.07B

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$447.57B +11.8%	$400.28B +7.7%	$371.62B +14.6%	$324.16B +12.7%	$287.60B +11.8%	$257.14B
Net Income	$12.06B -16.3%	$14.40B -35.6%	$22.38B +11.2%	$20.12B +16.4%	$17.29B +12.2%	$15.40B
Operating Income	$18.96B -41.3%	$32.29B -0.2%	$32.36B +13.8%	$28.43B +18.6%	$23.97B +7.0%	$22.41B
EPS (Diluted)	$13.23 -14.7%	$15.51 -35.0%	$23.86 +12.7%	$21.18 +17.1%	$18.08 +12.8%	$16.03
Total Assets	$309.58B +3.8%	$298.28B +9.0%	$273.72B +11.4%	$245.71B +15.8%	$212.21B +7.6%	$197.29B
Total Debt	$77.68B +2.0%	$76.18B +23.9%	$61.47B +8.3%	$56.76B +27.2%	$44.63B +5.6%	$42.28B
Operating Cash Flow	$19.70B -18.6%	$24.20B -16.7%	$29.07B +10.9%	$26.21B +17.3%	$22.34B +0.8%	$22.17B
Free Cash Flow	$16.07B -22.4%	$20.70B -19.4%	$25.68B +9.7%	$23.40B +17.7%	$19.89B -1.2%	$20.12B

AI Insight: UNH Financial Trends

UNH stabilized operationally in Q2 2026 after severe Q4 2025 collapse, but revenue remains volatile and profitability well below pre-disruption levels.

• Operating income rebounded to $7,991M in Q2 2026 from $380M in Q4 2025, suggesting operational recovery.

• Total debt declined to $73,328M in Q2 2026 from $78,010M in Q3 2024, strengthening balance sheet.

• Revenue volatility persists: Q2 2026 at $86,956M versus $111,721M in Q1 2026, indicating ongoing business instability.

⚠ Net income in Q2 2026 ($5,484M) remains 24% below Q3 2024 baseline ($6,055M) despite margin recovery.

⚠ Q4 2025 saw near-total net income collapse to $10M; root cause and ongoing impact unclear from financials.

AI Insight: UNH Ratio Trends

UNH rebounded sharply in H1 2026 after a catastrophic Q4 2025, but profitability remains well below pre-crisis levels.

• Operating margin collapsed from 11.2% in Q3 2024 to 0.3% in Q4 2025, then recovered to 9.2% in Q2 2026 — still 190bp below Q3 2024.

• ROIC plunged from 19.6% in Q3 2024 to 0.9% in Q4 2025; Q2 2026 recovery to 18.0% signals operational stabilization.

• Debt-to-equity improved from 0.81 in Q1 2025 to 0.70 in TTM, indicating leverage reduction despite margin pressure.

⚠ Q4 2025 near-total margin collapse (0.3% OpMargin, 0.0% NPM) remains unexplained; risk of recurrence unclear.

⚠ Q2 2026 margins still lag Q1 2025 (9.2% vs 8.3% OpMargin) despite sequential recovery — durability questionable.

Get alerted when UNH's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for UNITEDHEALTH GROUP INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of UNH

BlackRock, Inc.
$31.9B76,863,061 sh
VANGUARD CAPITAL MANAGEMENT LLC
$24.7B59,311,525 sh
STATE STREET CORP
$19.0B45,633,267 sh
Capital World Investors
$12.4B29,887,932 sh
FMR LLC
$11.6B27,992,995 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$10.2B24,483,234 sh
PRICE T ROWE ASSOCIATES INC /MD/
$9.6B23,153,813 sh
GEODE CAPITAL MANAGEMENT, LLC
$9.0B21,751,937 sh
JPMORGAN CHASE & CO
$8.5B20,246,047 sh
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$8.2B19,830,588 sh

Fund	Value	Shares
BlackRock, Inc.	$31.9B	76,863,061
VANGUARD CAPITAL MANAGEMENT LLC	$24.7B	59,311,525
STATE STREET CORP	$19.0B	45,633,267
Capital World Investors	$12.4B	29,887,932
FMR LLC	$11.6B	27,992,995
VANGUARD PORTFOLIO MANAGEMENT LLC	$10.2B	24,483,234
PRICE T ROWE ASSOCIATES INC /MD/	$9.6B	23,153,813
GEODE CAPITAL MANAGEMENT, LLC	$9.0B	21,751,937
JPMORGAN CHASE & CO	$8.5B	20,246,047
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$8.2B	19,830,588

Companies Similar to UNH

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

CVS

CVS HEALTH Corp

AI score

Very similar · 39 shared holders

Capital World Investors DODGE & COX Capital Research Global Investors

MRK

Merck & Co., Inc.

AI score

Very similar · 49 shared holders

Capital International Investors Grantham, Mayo, Van Otterloo & Co. LLC National Pension Service

ABBV

AbbVie Inc.

AI score

Very similar · 42 shared holders

Capital World Investors Capital Research Global Investors Capital International Investors

ABT

ABBOTT LABORATORIES

AI score

Very similar · 37 shared holders

Capital Research Global Investors Capital International Investors Grantham, Mayo, Van Otterloo & Co. LLC

JNJ

JOHNSON & JOHNSON

AI score

Very similar · 46 shared holders

Capital World Investors Capital Research Global Investors Grantham, Mayo, Van Otterloo & Co. LLC

PFE

PFIZER INC

AI score

Very similar · 30 shared holders

Capital World Investors National Pension Service PeakShares LLC

ELV

Elevance Health, Inc.

AI score

Very similar · 38 shared holders

Sanders Capital, LLC Grantham, Mayo, Van Otterloo & Co. LLC EAGLE CAPITAL MANAGEMENT LLC

WMT

Walmart Inc.

AI score

Very similar · 46 shared holders

National Pension Service Capital World Investors Capital International Investors

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put UNH on your watchlist

Track score changes the day UNITEDHEALTH GROUP INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is UNH a good stock to buy?

13F Pro's AI-powered analysis of UNITEDHEALTH GROUP INC (UNH) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for UNH are available on the UNH stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. UNH is classified as a mega company.

Which hedge funds own UNH?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling UNH. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of UNITEDHEALTH GROUP INC's investment landscape.